期刊文献+

不同地区双孢蘑菇中蘑菇氨酸含量的比较研究

Comparison of Agaritine Content of Fresh Mushroom (Agaricus bisporus) from Different Areas of China
暂未订购
导出
摘要 蘑菇氨酸曾被怀疑具有潜在的致癌效应,但其生理作用目前还存在争议。为比较分析我国不同地区双孢蘑菇中蘑菇氨酸含量,本研究采用反相高效液相色谱法检测了我国5个双孢蘑菇产区30份新鲜双孢蘑菇样品中蘑菇氨酸的含量。结果显示,我国双孢蘑菇中蘑菇氨酸含量范围较广,为155.6~934.4 mg/kg FW。在此基础上,分析了菌株类型、培养料类型和采收季节等因素对蘑菇氨酸含量的影响。结果表明,不同菌株、不同栽培条件下生产的双孢蘑菇中蘑菇氨酸的含量差异明显。 garitine was suspected of its potential carcinogenic effect, but its physiological role was still controversial. In this article, the agaritine contents of 30 fresh mushrom ( Agaricus bisporus ) from five provinces in China were detected by reverse-high performance liquid chromatography (HPLC). The results showed that the levels of agaritine in fresh mushroom were in the range of 155.6 ~ 934.4 mg/kg FW. Basicly, the factors which probably influenced the agaritine content of the cultivated mushroom from strain type, compost type and harvest season were also analyzed. The results in- dicated that the agaritine levels were greatly different in mushrooms which were produced by different strain type and un- der different cultivate conditions.
出处 《天然产物研究与开发》 CAS CSCD 北大核心 2012年第5期635-638,共4页 Natural Product Research and Development
基金 科技部国家支撑计划(2008BADA1B08-3) 上海市农委项目(10-3-2004)
关键词 双孢蘑菇 蘑菇氨酸 高效液相色谱 Agaricus bisporus agaritine HPLC
  • 相关文献

参考文献1

二级参考文献10

  • 1Debouck C. The HIV-I protease as therapeutic target for AIDS. [J]. AIDS Res Hum Retrovir, 1992, 8(2): 153-164.
  • 2Martin J A. Recent advances in the design of HIV proteinase inhibitors [J]. Antivi Res, 1992, 17(4): 265-278.
  • 3Espn J C, Jolivet S, Overeem A, et al. Agaritine from Agaricus bisporus is capable of preventing melanin formation.[J]. Phytochemistry, 1999, 50(4): 555-563.
  • 4Baumgartner D, Hoeschand L, Rast D M, et al. The biogenesis of β-N-(γ-glutamyl )-4-hydroxymethylphenylhydrazine (agaritine) in Agaricus bisporus in honour of Professor G. H. Neil towers 75th birthday [J]. Phytochemistry, 1998, 49 (2) : 465-474.
  • 5Boffito M, Kurowski M, Kruse G, et al. Atazanavir enhances saquinavir hard-gel concentrations in a ritonavirboosted once-daily regimen [J].AIDS, 2004, 18: 1291- 1297.
  • 6Plosker G, Scott L. Saquinavir: A review of its use in boosted regimens for treating HIV infection [J]. Drugs, 2003,63:1299-1324.
  • 7Porte C J, Wasmuth J C, Schneider K, et al. Lopinavir/ritonavir plus saquinavir in salvage therapy ; pharmacokinetics, tolerability and efficacy [J]. AIDS, 2003, 17: 1700-1702.
  • 8Cameron D W, Japour A J, Xu Y, et al. Ritonavir and saquinavir combination therapy for the treatment of HIV infection[J]. AIDS, 1999, 13: 213-224.
  • 9Bohm H J. The Development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure [J]. Cornput Aided Mol Des, 1994, 8: 243-248.
  • 10Bohm H J. LUDI: Rule-based automatic design of new substituents for enzyme inhibitor leads[J]. Comput Aided Mol Des, 1992, 6: 593-596.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部